Astrocytes were once thought to be mere support cells, passive caretakers providing structural and metabolic assistance to neurons. However, a groundbreaking initiative, funded by the U.S. Army’s Multi-University Research Initiative (MURI), is challenging this narrow view. Led by a multidisciplinary team from the University of Maryland and Claremont Colleges, the project seeks to unravel the computational secrets of astrocytes and integrate these insights into next-generation AI architectures. Their goal is nothing short of transformative: to engineer “hybrid AI” systems that blend conventional computing with bio-inspired mechanisms, thereby crafting machines that learn, adapt, and think more like the human brain.

The conceptual leap embraced by this initiative stems from a critical insight about the brain’s cellular makeup. While neurons transmit information at lightning speed—milliseconds or less—astrocytes operate on a much slower timescale, processing signals over seconds. This temporal distinction hints at complementary functional roles: neurons handle rapid, moment-to-moment computations, whereas astrocytes integrate information over longer windows, acting like a “slow-burn” memory system that stabilizes and modulates neural activity. By mimicking this duality, artificial neural networks could harness new dimensions of learning and resilience.

The team’s pioneering research began with the development of a hybrid AI network that explicitly models both artificial neurons and astrocytes wired together to emulate their interaction in the brain. Published in the journal Neurocomputing, this model revealed striking performance advantages. Networks containing approximately twice as many astrocytes as neurons—the same ratio found in human brains—outperformed those composed exclusively of either cell type alone. This synergy suggests that the collaboration between neurons and astrocytes is not just complementary but essential for efficient computation.

With the initial biological framework established, the researchers delved deeper into the intrinsic dynamics of astrocytes, particularly their characteristic slow oscillating waves. Unlike the steady, static connections commonly used in traditional AI, astrocyte communication entails rhythmic, pulsatile fluctuations that modulate synaptic strengths over time. Incorporating these rhythmic variations into their neural models led to the invention of a novel algorithm dubbed “rhythmic sharing,” in which AI network connections continuously pulse and shift. This rhythmic modulation challenges the AI status quo, where link strengths remain fixed after training, potentially unlocking adaptive capabilities that mirror the brain’s plasticity.

Remarkably, this rhythmic sharing algorithm transcended theory and demonstrated tangible superiority in applied scenarios. Tested against conventional AI systems on simulated anomaly detection tasks—such as monitoring water treatment facilities under cyberattack and predicting jet engine failures—the astrocyte-inspired network detected environmental shifts more quickly and reliably. These results, published in npj Unconventional Computing, underscore the potential of astrocyte-based AI to excel in dynamic, real-world environments where traditional models can fail silently when conditions drift subtly over time.

The rhythmic sharing network’s ability to synchronize continuous internal pulse patterns makes it exquisitely sensitive to early signs of change. Unlike standard AI systems that may overlook gradual deviations until damage becomes manifest, this novel algorithm “listens” to the internal rhythms and signals disturbances before they become problematic. This anticipatory capability is akin to a sentinel always on guard, offering a new paradigm for real-time monitoring, predictive maintenance, and anomaly detection across sectors ranging from industrial infrastructure to cybersecurity.

Beyond immediate applications, this research opens a treasure trove of possibilities for understanding how the brain’s hidden half contributes to cognition. Astrocytes participate actively in modulating synaptic transmission, regulating neurotransmitter levels, and managing blood flow—all vital for learning, memory formation, and adaptive behavior. By abstracting these biological functions into computational algorithms, hybrid AI systems can bridge the gap between rigid traditional models and fluid, context-aware problem-solving, paving the way for more organic machine intelligence.

Professor Wolfgang Losert, a physicist at the University of Maryland and co-leader of the project, emphasized the significance of this paradigm shift. “We’re harnessing algorithms rooted in biological computation hidden from view because they do not rely on electrical signaling like neurons do,” he said. “Astrocytes are dynamic participants in cognitive processes, and translating their mechanisms into AI can lead to more robust and efficient learning models that outperform today’s neural-network-based approaches.”

This work is the culmination of years of interdisciplinary collaboration, integrating principles from physics, chemistry, electrical engineering, and computer science. It reflects the growing recognition that innovation in AI will increasingly depend on insights gleaned from biology’s complexity and adaptability. Foundational studies of living astrocytes in the Losert lab, supported by the Air Force Office of Scientific Research’s biophysics program, provided the experimental backbone to inform and validate these groundbreaking computational frameworks.

Looking forward, the team envisions hybrid AI architectures that continuously adapt to fluctuating conditions by leveraging astrocyte-like modulation. Such systems could revolutionize not only anomaly detection but broader cognitive tasks by maintaining stable yet flexible representations of data over time, akin to human brain function. The ultimate ambition is to bridge human and machine intelligence more closely, bringing AI out of the narrow realm of static pattern recognition into an arena of dynamic understanding and real-time learning.

As these explorations continue, the implications ripple across numerous fields—from health monitoring, where early detection of physiological abnormalities could save lives, to communication technologies that adapt fluidly to changing signals, to autonomous systems functioning reliably in unpredictable environments. The astrocyte model enriches AI’s conceptual toolkit, introducing temporal layering and rhythmic dynamism as core computational ingredients.

In sum, the astrocyte-inspired hybrid AI initiative not only expands our understanding of the brain’s hidden half but also charts a promising pathway for advancing AI beyond its current neuron-centric paradigm. By embracing the rich interplay of slow and fast cellular processes, these hybrid networks could mark the dawn of a new era in which artificial intelligence learns, adapts, and senses the world in ways eerily reminiscent of the human mind.

Subject of Research: Artificial intelligence inspired by astrocyte-neuron interactions in the human brain.

Article Title: Emergent detection of concept drift within the glia-inspired ‘rhythmic sharing’ algorithm.

News Publication Date: June 3, 2026.

Web References:

• Hybrid AI project: https://hybrid-ai.umd.edu/
• University of Maryland Invention of the Year Award: https://cmns.umd.edu/news-events/news/2025-invention-year-awards
• DOI link to npj Unconventional Computing article: http://dx.doi.org/10.1038/s44335-026-00067-3

References:

• Yang et al., Neurocomputing (2026).
• Losert et al., Physical Review Research.
• Ian Whitehouse et al., npj Unconventional Computing (2026).

Image Credits: Yang et al., Neurocomputing (2026).

Keywords

Artificial intelligence, Artificial neural networks, Artificial consciousness, Quantum computing, Supercomputing, Brain, Brain structure, Gray matter, Human brain, Neural pathways

The study’s approach was notably distinct from prior efforts that focused primarily on prenatal intervention. Rather than targeting the narrow window of brain development in the womb, the researchers demonstrated that adult brains could be modulated by delivering pleiotrophin, which modulates synapse formation and neural circuitry. This revelation challenges long-held assumptions about the fixed nature of brain architecture after early development and suggests that adult interventions may prove viable and impactful. It also circumvents the enormous complexities and risks associated with administering treatments during pregnancy.

Central to this research is the role of astrocytes, specialized glial cells in the central nervous system traditionally overshadowed by neurons in neurological studies. Astrocytes are now recognized for their ability to secrete synapse-modulating molecules and maintain homeostasis in neural environments. By focusing on these cells as targets for delivering pleiotrophin, the team discovered a novel mechanism to promote brain plasticity. This strategy leverages astrocytes’ natural secretory capacities to influence synaptic connections dynamically, which is a paradigm shift in designing gene therapies and protein-based treatments.

Down syndrome, a genetic disorder caused by trisomy 21, affects about 1 in 640 live births in the United States and manifests in diverse neurological and physiological symptoms such as developmental delay, cognitive impairment, and a propensity for congenital heart defects. The complexity of the syndrome’s pathophysiology has long posed challenges for researchers seeking therapeutic interventions. The identification of pleiotrophin’s depletion as a significant contributor to defective neural circuits in Down syndrome offers a critical molecular target to address these multifactorial difficulties.

In their methodical investigation, the researchers employed a Down syndrome mouse model to map the expression patterns of various cellular proteins in the brain. Pleiotrophin stood out due to its high concentration during pivotal phases of neural development, its role in synaptogenesis, and its facilitation of axonal and dendritic growth. Remarkably, this protein’s expression was found to be markedly diminished in the Down syndrome brain, implying a direct link between pleiotrophin shortage and impaired neural connectivity.

To delve deeper into the functional consequences of pleiotrophin deficiency, the team used viral vectors—engineered viruses stripped of pathogenic components—to deliver the gene encoding pleiotrophin specifically to astrocytes in the hippocampus. The hippocampus, a brain region vital for memory consolidation and learning, exhibited significant synaptic improvement post-treatment. These viral vectors, tailored for gene therapy applications, facilitate targeted delivery and expression of therapeutic genes, marking a precise and innovative approach to reprogram brain circuits.

The results were striking: pleiotrophin delivery led to a pronounced increase in synapse number and enhanced synaptic plasticity, the adaptive capacity of neural networks underlying cognitive flexibility. Such plasticity is crucial for learning, memory formation, and overall brain resilience. This demonstrates a tangible restoration of neural functions in adult brains previously considered relatively immutable, igniting hope for reversing cognitive deficits later in life.

Furthermore, the restoration procedure harnessed astrocytes’ natural ability to modulate synaptic environments, effectively turning them into biological vectors that promote plasticity-inducing molecular delivery. This concept, as elucidated by the study’s lead investigators, could pave the way for rewiring dysfunctional neural circuits not only in Down syndrome but across an array of neurodevelopmental and neurodegenerative pathologies.

While the findings herald promising therapeutic potential, the researchers emphasize that pleiotrophin deficiency is unlikely to be the sole contributor to the complex neurological landscape of Down syndrome. The disorder involves multiple genetic and cellular pathways, demanding comprehensive exploration to untangle its mechanistic intricacies. Such multidimensional investigation remains crucial to developing multifaceted treatment regimens tailored for maximum efficacy.

The implications of astrocyte-mediated delivery of synaptogenic molecules extend beyond Down syndrome. Disorders such as fragile X syndrome, characterized by synaptic dysfunction and cognitive impairment, may also benefit from similar strategies. Moreover, neurodegenerative conditions like Alzheimer’s disease, typified by progressive synaptic loss, could potentially be ameliorated through reprogramming of astrocytes to bolster synapse formation and resilience.

Ashley N. Brandebura, PhD, a principal researcher formerly at the Salk Institute and now at the University of Virginia School of Medicine, highlighted the significance of this work for the broader neuroscience community. She underscored the transformative prospects of gene therapy and protein infusion approaches that target astrocytes to effectuate brain rewiring, offering a fresh paradigm for treating neurological diseases that currently lack effective therapeutic options.

Brandebura’s continued research at UVA, supported by affiliations with the UVA Brain Institute and the Center for Brain Immunology and Glia (BIG Center), aims to refine these cutting-edge therapies and extend their applications. The team’s commitment to unraveling the molecular underpinnings of brain plasticity could catalyze a new era of personalized medicine for patients with genetic and acquired brain disorders.

The research findings were published in the open-access journal Cell Reports, allowing unfettered access to these transformative insights. Supported by generous funding from the Chan Zuckerberg Initiative and the National Institute of Neurological Disorders and Stroke (NIH), this work epitomizes the power of collaborative, interdisciplinary efforts advancing neuroscience frontiers.

In summary, this study redefines the potential for adult brain remodeling in the context of genetic conditions such as Down syndrome. The targeted restoration of pleiotrophin via astrocytes emerges as a beacon of hope, revealing that enduring cognitive impairments may one day be mitigated through sophisticated molecular therapies. As the scientific community continues to explore brain plasticity at the cellular level, these findings offer an inspiring glimpse into a future where neurological diseases are not merely managed but genuinely reversed.

Subject of Research: Down syndrome and neurological diseases; brain plasticity; astrocyte-mediated gene therapy; synaptic modulation; pleiotrophin protein function.

Article Title: Missing Molecule May Explain Down Syndrome and Offer New Therapeutic Pathways

News Publication Date: Not specified in text

Web References:

• DOI link to article in Cell Reports
• UVA Making of Medicine blog (http://makingofmedicine.virginia.edu/)

References:
Brandebura, A. N., Paumier, A., Asbell, Q. N., Tao, T., Micael, M. K. B., Sanchez, S., & Allen, N. J. (2025). Cell Reports.

Image Credits: UVA Health

Keywords: Down syndrome, genetic disorders, neurodevelopmental disorders, astrocytes, synaptic plasticity, pleiotrophin, gene therapy, neuroscience, neurogenetics, neurodegenerative diseases, hippocampus, biomedical engineering